SCIENTURE HOLDINGS, INC. Share-based Payment Arrangement, Option, Exercise Price Range, Upper Range Limit
SCIENTURE HOLDINGS, INC. (SCNX) reported Share-based Payment Arrangement, Option, Exercise Price Range, Upper Range Limit of $0.50 per share for the 1-month period ending 2018-04-30, per its 10-K filed 2019-03-22.
Discontinued › Notes › Share-Based Payment Arrangement, Disclosure
us-gaap:ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeUpperRangeLimit · last filed 2019-03-22
- 2018-04-30: Share-based Payment Arrangement, Option, Exercise Price Range, Upper Range Limit 1 month $0.50.
- 2017-04-30: Share-based Payment Arrangement, Option, Exercise Price Range, Upper Range Limit 1 month $0.65.
| Period end | Share-based Payment Arrangement, Option, Exercise Price Range, Upper Range Limit 1 month |
|---|---|
| 2018-04-30 | $0.50 10-K · filed 2019-03-22 |
| 2017-04-30 | $0.65 10-K · filed 2019-03-22 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| KIORA PHARMACEUTICALS INC (KPRX) | United States | $0.012B | |
| Phio Pharmaceuticals Corp. (PHIO) | United States | $0.012B | -0.92 |
| ADIAL PHARMACEUTICALS, INC. (ADIL) | United States | $0.012B | |
| Dare Bioscience, Inc. (DARE) | United States | $0.011B | |
| BIOVIE INC. (BIVI) | United States | $0.012B | |
| Aspire Biopharma Holdings, Inc. (ASBP) | United States | $0.012B | -0.60 |
| Tempest Therapeutics, Inc. (TPST) | United States | $0.013B | |
| Moleculin Biotech, Inc. (MBRX) | United States | $0.011B | |
| MetaVia Inc. (MTVA) | United States | $0.011B | -0.65 |
| KALA BIO, Inc. (KALA) | United States | $0.011B | -3.33 |